Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography

Transplantation

Volumn 93, Issue 11, 2012, Pages 1125-1129

  Kihm, Lars P ^a   Blume, Carsten ^a   Seckinger, Jörg ^a   Hankel, Vinzent ^a   Stoffler, Dominik ^a   Morath, Christian ^a   Zeier, Martin ^a   Schwenger, Vedat ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Contrast sonography; Cyclosporine; Kidney transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCED SONOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; DRUG BLOOD LEVEL; DRUG EFFECT; ECHOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FLOW MEASUREMENT; GLOMERULUS FILTRATION RATE; GRAFT PERFUSION; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT MICROPERFUSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; MALE; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TISSUE PERFUSION; ULTRASOUND SCANNER;

ADOLESCENT; ADULT; AGED; CALCINEURIN; CONTRAST MEDIA; CYCLOSPORINE; ENZYME INHIBITORS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICROVESSELS; MIDDLE AGED; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 84862293366     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31824f3dae     Document Type: Article

References (43)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
3. Kreis HA, Ponticelli C. Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors. Transplantation 2001; 71: SS5.
4. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
5. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
6. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: Evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6: 1111.
7. Perico N, Ruggenenti P, Gaspari F, et al. Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 1992; 54: 56.
8. Nankivell BJ, Chapman JR, Bonovas G, et al. Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. Transplantation 2004; 77: 1457.
9. Radermacher J, Meiners M, Bramlage C, et al. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 1998; 11: 3.
10. Klein IH, Abrahams A, van Ede T, et al. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002; 73: 732.
11. Krumme B, Grotz W, Kirste G, et al. Determinants of intrarenal Doppler indices in stable renal allografts. JAmSoc Nephrol 1997; 8: 813.
12. Radermacher J, Mengel M, Ellis S, et al. The renal arterial resistance index and renal allograft survival. N Engl J Med 2003; 349: 115.
13. Schwenger V, Keller T, Hofmann N, et al. Color Doppler indices of renal allografts depend on vascular stiffness of the transplant recipients. Am J Transplant 2006; 6: 2721.
14. Schwenger V, Korosoglou G, Hinkel UP, et al. Real-time contrastenhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant 2006; 6: 609.
15. Kihm LP, Hinkel UP, Michael K, et al. Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus. Transplantation 2009; 88: 261.
16. Watarai Y, Morita K, Shimoda N, et al. Effect of tacrolimus and cyclosporine on renal microcirculation and nitric oxide production. Transplant Proc 2004; 36: 2130.
17. Conte G, Dal Canton A, Sabbatini M, et al. Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989; 36: 1086.
18. Nankivell BJ, Chapman JR, Gruenewald SM. Detection of chronic allograft nephropathy by quantitative Doppler imaging. Transplantation 2002; 74: 90.
19. Tranquart F, Claudon M, Correas JM. Guidelines for the use of contrast agents in ultrasound. J Radiol 2005; 86: 1047.
20. McNally PG, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992; 7: 791.
21. Kaye D, Thompson J, Jennings G, et al. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation 1993; 88: 1101.
22. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993; 43: 706.
23. Hansen JM, Fogh-Andersen N, Christensen NJ, et al. Cyclosporineinduced hypertension and decline in renal function in healthy volunteers. J Hypertens 1997; 15: 319.
24. Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985; 28: 767.
25. Textor SC, Burnett JC Jr, Romero JC, et al. Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 1995; 47: 1426.
26. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985; 82: 8222.
27. Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 2000; 13: 999.
28. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitricoxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem 2002; 277: 29669.
29. Lungu AO, Jin ZG, Yamawaki H, et al. Cyclosporin A inhibits flowmediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae. J Biol Chem 2004; 279: 48794.
30. Roullet JB, Xue H, McCarron DA, et al. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 1994; 93: 2244.
31. Benigni A, Morigi M, Perico N, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 1992; 54: 775.
32. Cantarovich D, Renou M, Megnigbeto A, et al. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events. Transplantation 2005; 79: 72.
33. Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report. J Am Soc Nephrol 2006; 17: 3257.
34. Venkat Raman G, Feehally J, Coates RA, et al. Renal effects of amlodipine in normotensive renal transplant recipients. Nephrol Dial Transplant 1999; 14: 384.
35. Rahn KH, Barenbrock M, Fritschka E, et al. Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: A randomised trial. Lancet 1999; 354: 1415.
36. Kuypers DR, Neumayer HH, Fritsche L, et al. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study. Transplantation 2004; 78: 1204.
37. Kay DH, Mazonakis M, Geddes C, et al. Ultrasonic microbubble contrast agents and the transplant kidney. Clin Radiol 2009; 64: 1081.
38. Mitterberger M, Pinggera GM, Colleselli D, et al. Acute pyelonephritis: Comparison of diagnosis with computed tomography and contrastenhanced ultrasonography. BJU Int 2008; 101: 341.
39. Granata A, Andrulli S, Fiorini F, et al. Diagnosis of acute pyelonephritis by contrast-enhanced ultrasonography in kidney transplant patients. Nephrol Dial Transplant 2011; 26: 715.
40. Mahalati K, Belitsky P, Sketris I, et al. Neoral monitoring by simplified sparse sampling area under the concentration-time curve: Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation. Transplantation 1999; 68: 55.
41. Levy G, Thervet E, Lake J, et al. Patient management by Neoral C(2) monitoring: An international consensus statement. Transplantation 2002; 73: S12.
42. Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25: 249.
43. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.